Osstell Beacon is available in US
WHITE OAK, Md., U.S./GOTHENBURG, Sweden: Osstell, the developer of the proprietary diagnostic technology Osstell ISQ (Implant Stability Quotient), has announced that the Osstell Beacon is now available in the U.S. after receiving clearance from the Food and Drug Administration. The Osstell Beacon is a new, innovative and highly intuitive tool designed to assess dental implant stability.
Patients—the priority for Osstell and its users—are increasingly well informed before seeking implant treatment and are often aware of available treatment options. They are increasingly expecting shorter treatment protocols. In addition, there is a growing aging and medically compromised patient population for whom healing, for many reasons, can be unpredictable. In order to meet these demands and changing demographics, there is a need for innovative diagnostic tools to help the individual clinician deliver these treatment protocols while ensuring predictability and patient satisfaction. The more than 1,000 studies where Osstell ISQ technology has been used provide evidence that Osstell ISQ diagnostics can help improve outcomes and quality by using objective data to guide and optimize the implant treatment for both complex and more straightforward cases.
Optimize restorative protocol
The Osstell ISQ technology can assist when determining the patient-specific restorative protocol. It can help the clinician to decide when each implant of an individual patient is ready to be restored, both with temporary solutions as well as with the final restoration.
Ease of use
The Osstell Beacon makes the stability measurement very intuitive. The Osstell ISQ measurements are presented also with a colored indication on the instrument, as a result of the clinical evidence gained from using the Osstell ISQ scale. This gives a visual aid of the implant stability status.
Osstell’s Vice President of Product Development Stefan Horn said, “We have listened to our users who need easy to use and intuitive tools to assess implant stability. Accordingly, we have developed a complement to the more comprehensive Osstell IDx to meet the needs from all clinicians, from small private practices to large university clinics. Although very advanced on the inside, we believe that the Osstell Beacon will be appreciated for its ease of use and making the stability measurement very intuitive.”
Osstell is currently also focusing on developing a new concept combining the best of the Osstell Beacon and the current Osstell IDx. This concept, called Osstell IDx Pro, will allow the user to take a measurement with the wireless, smart and very intuitive Osstell Beacon and visualize implant stability development on the large display and comprehensive user interface of the Osstell IDx, combined with patient data storage and full connectivity.
“Osstell’s innovative and patented technology helps dentists around the world to make dental implant treatments more predictable, thereby helping clinicians improve patient confidence and comfort. We always aim to serve our customers and users with ever better products and services as well as help them to provide best practice services to their customers—the patients. Patients’ well-being is always the top priority. With this—the Osstell Beacon—being the newest addition, we take another important major step towards making our technology, products and approach even more accessible,” said Jonas Ehinger, CEO of Osstell.